According to the latest report published by Data Bridge Market Research, the Radiopharmaceuticals Market
CAGR Value
During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 6.50%, primarily driven by the rising prevalence of cancer and cardiovascular diseases, along with increasing adoption of targeted diagnostic and therapeutic procedures...